— Know what they know.
Not Investment Advice
Also trades as: CSLLY (OTC) · $vol 11M · CMXHF (OTC) · $vol 0M

CSL.AX ASX

CSL Limited
1W: -0.9% 1M: +1.2% 3M: +41.5% YTD: +2.3% 1Y: -14.9% 3Y: -32.6% 5Y: -39.2%
A$177.21 ($123.23)
+1.85 (+1.06%)
 
Weekly Expected Move ±3.5%
A$163 A$169 A$175 A$182 A$188
ASX · Healthcare · Biotechnology · Tech Score Buy · Power 59 · A$84.0B mcap · 482M float · 0.330% daily turnover

📊 Key Metrics

TTM
A$31B
Revenue
+10.1% YoY
A$509M
Net Income
-93.1% YoY
A$6B
Free Cash Flow
+139.6% YoY
44.4%
Gross Margin
19.0%
Op. Margin
-40.2%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE3.2%
ROA1.4%
ROIC24.2%

Valuation

P/E-23.1
P/B4.0
EV/EBITDA0.0

Leverage

Debt/Equity0.74
Current Ratio2.21
Interest Cov.9.6x

Quality Scores

Piotroski F6/9
Altman Z—
Beneish M-3.22

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms